Perspective Therapeutics Inc (CATX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Sales | 1,066 | 1,042 | 0 | 1,134 | 1,085 |
| Cost of Goods | 1,104 | 1,097 | N/A | 1,083 | 1,119 |
| Gross Profit | -38 | -55 | N/A | 51 | -34 |
| Operating Expenses | -1,000 | 1,203 | 0 | 1,123 | -1,000 |
| Operating Income | -1,020 | -1,161 | N/A | -989 | -1,044 |
| Interest Expense | 0 | 4 | 0 | 0 | 0 |
| Other Income | 1,020 | 379 | 0 | -1,094 | 118 |
| Pre-tax Income | 0 | -786 | 0 | -2,083 | -927 |
| Net Income Continuous | N/A | -786 | N/A | -2,083 | N/A |
| Net Income | $N/A | $-786 | $N/A | $-2,083 | $N/A |
| EPS Basic Total Ops | -0.20 | -0.10 | N/A | -0.50 | -0.20 |
| EPS Basic Continuous Ops | N/A | -0.14 | N/A | -0.49 | N/A |
| EPS Diluted Total Ops | -0.20 | -0.10 | N/A | -0.50 | -0.20 |
| EPS Diluted Continuous Ops | N/A | -0.14 | N/A | -0.49 | N/A |
| EBITDA(a) | $1,229 | $-1,161 | $N/A | $-393 | $1,302 |